Novonesis
Irem Alvemar is a seasoned professional in corporate strategy and management with extensive experience in leading strategic projects and initiatives across multiple organizations. Currently serving as the Corporate Strategy and M&A Manager at Novonesis since January 2024, Irem previously held the role of Manager Corporate Strategy at Novozymes, where responsibilities included corporate strategy formulation, merger integration planning, and change management. Prior to Novozymes, Irem spent eight years at Volvo Group in various leadership positions such as Director Group Strategy, Director Executive Board Coordination, and Director Corporate Social Responsibility, focusing on driving strategic investigations, managing cross-functional stakeholders, and implementing CSR strategies. Earlier career highlights include work as a Management Consultant at Volvo Group and SAP MM Consultant at Bimsa. Irem holds a Master of Science in Innovation & Industrial Management from the University of Gothenburg and a Bachelor of Science in Industrial Engineering from Sabanci University.
This person is not in any teams
This person is not in any offices
Novonesis
44 followers
At Novonesis, we believe solutions rooted in biology are key to tackling the challenges our world faces. Enzymes, functional proteins and microorganisms are our planet's tiniest, yet mightiest agents of change. When we leverage their power with science, we create biosolutions that transform the way we all produce, consume and live. Today, we are 10,000 people worldwide whose expertise spans more than 30 different industries. All around the world our biosolutions already create value for thousands of customers and benefit the planet. Our solutions enable feeding and fueling the world more sustainably, from healthy and sustainable nutrition to biofuel. Biosolutions also reduce the use of fossil-based resources, chemicals, energy and water. And this is just the beginning. The potential is almost endless. The time for biosolutions is now. And by working closely with our partners and customers, we will continue to challenge conventional thinking and transform business with biology. Together, we will create the change our world needs. Let’s better our world with biology.